UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Discovery of a Potent, Orally Bioavailable β3 Adrenergic Receptor Agonist, (R)-N-[4-[2-[[2-Hydroxy-2-(3-pyridinyl)ethyl]amino]ethyl]phenyl]-4-[4-[4-(trifluoromethyl)phenyl]thiazol-2-yl]benzenesulfonamide

Journal of medicinal chemistry, 2000-10, Vol.43 (21), p.3832-3836

2000

Volltextzugriff (PDF)

Human β3-Adrenergic receptor agonists containing 1,2,3-triazole-substituted benzenesulfonamides

Bioorganic & medicinal chemistry letters, 2000-09, Vol.10 (18), p.2111-2114

2000

Volltextzugriff (PDF)

Activation of melanocortin MC4 receptors increases erectile activity in rats ex copula

European journal of pharmacology, 2002-11, Vol.454 (1), p.71-79

2002

Volltextzugriff (PDF)

Synthesis and SAR of benzyl and phenoxymethylene oxadiazole benzenesulfonamides as selective β3 adrenergic receptor agonist antiobesity agents

Bioorganic & medicinal chemistry letters, 2000-07, Vol.10 (13), p.1431-1434

2000

Volltextzugriff (PDF)

Discovery of an orally bioavailable alkyl oxadiazole β3 adrenergic receptor agonist

Bioorganic & medicinal chemistry letters, 2000-07, Vol.10 (13), p.1427-1429

2000

Volltextzugriff (PDF)

Human β 3-adrenergic receptor agonists containing 1,2,3-triazole-substituted benzenesulfonamides

Bioorganic & medicinal chemistry letters, 2000-09, Vol.10 (18), p.2111-2114

2000

Volltextzugriff (PDF)

3-Pyridyloxypropanolamine agonists of the β3 adrenergic receptor with improved pharmacokinetic properties

Bioorganic & medicinal chemistry letters, 1998-08, Vol.8 (16), p.2111-2116

1998

Volltextzugriff (PDF)

L-770,644: A potent and selective human β3 adrenergic receptor agonist with improved oral bioavailability

Bioorganic & medicinal chemistry letters, 1999-05, Vol.9 (9), p.1251-1254

1999

Volltextzugriff (PDF)

Human β3 adrenergic receptor agonists containing imidazolidinone and imidazolone benzenesulfonamides

Bioorganic & medicinal chemistry letters, 1999-03, Vol.9 (5), p.755-758

1999

Volltextzugriff (PDF)

3-pyridylethanolamines : Potent and selective human β3 adrenergic receptor agonists

Bioorganic & medicinal chemistry letters, 1998-11, Vol.8 (21), p.3087-3092

1998

Volltextzugriff (PDF)

Activation of melanocortin MC(4) receptors increases erectile activity in rats ex copula

European journal of pharmacology, 2002-11, Vol.454 (1), p.71-79

2002

Volltextzugriff (PDF)

Activation of melanocortin MC 4 receptors increases erectile activity in rats ex copula

European journal of pharmacology, 2002, Vol.454 (1), p.71-79

2002

Volltextzugriff (PDF)

Potent, selective 3-pyridylethanolamine β3 adrenergic receptor agonists possessing a thiazole benzenesulfonamide pharmacophore

Bioorganic & medicinal chemistry letters, 2000-09, Vol.10 (17), p.1971-1973

2000

Volltextzugriff (PDF)

Discovery of a Potent, Orally Bioavailable β 3 Adrenergic Receptor Agonist, ( R )- N -[4-[2-[[2-Hydroxy-2-(3-pyridinyl)ethyl]amino]ethyl]phenyl]-4-[4-[4-(trifluoromethyl)phenyl]thiazol-2-yl]benzenesulfonamide

Journal of medicinal chemistry, 2000-10, Vol.43 (21), p.3832-3836

2000

Volltextzugriff (PDF)

Potent, selective 3-pyridylethanolamine β 3 adrenergic receptor agonists possessing a thiazole benzenesulfonamide pharmacophore

Bioorganic & medicinal chemistry letters, 2000, Vol.10 (17), p.1971-1973

2000

Volltextzugriff (PDF)

Physiological and pharmacological properties of vanadium

Life Sciences, 1983-01, Vol.33 (14), p.1325-1340

1983

Volltextzugriff (PDF)

Synthesis and SAR of benzyl and phenoxymethylene oxadiazole benzenesulfonamides as selective β 3 adrenergic receptor agonist antiobesity agents

Bioorganic & medicinal chemistry letters, 2000, Vol.10 (13), p.1431-1434

2000

Volltextzugriff (PDF)

Discovery of an orally bioavailable alkyl oxadiazole β 3 adrenergic receptor agonist

Bioorganic & medicinal chemistry letters, 2000, Vol.10 (13), p.1427-1429

2000

Volltextzugriff (PDF)

Human β3 adrenergic receptor agonists containing cyclic ureidobenzenesulfonamides

Bioorganic & medicinal chemistry letters, 1999-03, Vol.9 (5), p.749-754

1999

Volltextzugriff (PDF)

3-pyridylethanolamines: Potent and selective human β 3 adrenergic receptor agonists

Bioorganic & medicinal chemistry letters, 1998-11, Vol.8 (21), p.3087-3092

1998

Volltextzugriff (PDF)

Human β3 andrenergic receptor agonists containing imidazolidinone and imidazolone benzenesulfonamides

Bioorganic & medicinal chemistry letters, 1999-03, Vol.9 (5), p.755-758

1999

Volltextzugriff (PDF)

Effects of acute blood volume expansion on vascular resistance and reactivity in anaesthetized dogs

Clinical science (1979), 1983-07, Vol.65 (1), p.9-17

1983

Volltextzugriff (PDF)

Presynaptic inhibition of vascular sympathetic neurotransmission by adenosine

European journal of pharmacology, 1981-01, Vol.69 (1), p.101-106

1981

Volltextzugriff (PDF)

In vivo hemodynamic effects of endothelium-derived constricting factor in the dog

Drug development research, 1989, Vol.18 (2), p.145-151

1989

Volltextzugriff (PDF)

1 – 25 von 59

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(58)
Mit Volltextzugriff
(57)

Publikationsform

Artikel
(58)
Webseiten
(1)

Sprache

Englisch
(59)

Erscheinungsjahr

n.n

Thema

Science & Technology
(29)
Life Sciences & Biomedicine
(28)
Biological And Medical Sciences
(19)
Humans
(17)
Medical Sciences
(17)
Animals
(15)
Male
(15)
Female
(14)
Pharmacology. Drug Treatments
(14)
Dogs
(8)
Pharmacology & Pharmacy
(8)
Child
(6)
General And Cellular Metabolism. Vitamins
(6)
Neuropharmacology
(6)
Neurotransmitters. Neurotransmission. Receptors
(6)
Adult
(5)
Catecholaminergic System
(5)
Child, Preschool
(5)
Dentistry
(4)
Dentistry, Oral Surgery & Medicine
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Discovery of a Potent, Orally Bioavailable β3 Adrenergic Receptor Agonist, (R)-N-[4-[2-[[2-Hydroxy-2-(3-pyridinyl)ethyl]amino]ethyl]phenyl]-4-[4-[4-(trifluoromethyl)phenyl]thiazol-2-yl]benzenesulfonamide

Design and Pharmacology of N-[(3R)-1,2,3,4-Tetrahydroisoquinolinium- 3-ylcarbonyl]-(1R)-1-(4-chlorobenzyl)- 2-[4-cyclohexyl-4-(1H-1,2,4-triazol- 1-ylmethyl)piperidin-1-yl]-2-oxoethylamine (1), a Potent, Selective, Melanocortin Subtype-4 Receptor Agonist

Human β3-Adrenergic receptor agonists containing 1,2,3-triazole-substituted benzenesulfonamides

Activation of melanocortin MC4 receptors increases erectile activity in rats ex copula

Synthesis and SAR of benzyl and phenoxymethylene oxadiazole benzenesulfonamides as selective β3 adrenergic receptor agonist antiobesity agents

Discovery of an orally bioavailable alkyl oxadiazole β3 adrenergic receptor agonist

Human β 3-adrenergic receptor agonists containing 1,2,3-triazole-substituted benzenesulfonamides

3-Pyridyloxypropanolamine agonists of the β3 adrenergic receptor with improved pharmacokinetic properties

L-770,644: A potent and selective human β3 adrenergic receptor agonist with improved oral bioavailability

Human β3 adrenergic receptor agonists containing imidazolidinone and imidazolone benzenesulfonamides

3-pyridylethanolamines : Potent and selective human β3 adrenergic receptor agonists

Activation of melanocortin MC(4) receptors increases erectile activity in rats ex copula

Activation of melanocortin MC 4 receptors increases erectile activity in rats ex copula

Potent, selective 3-pyridylethanolamine β3 adrenergic receptor agonists possessing a thiazole benzenesulfonamide pharmacophore

Discovery of a Potent, Orally Bioavailable β 3 Adrenergic Receptor Agonist, ( R )- N -[4-[2-[[2-Hydroxy-2-(3-pyridinyl)ethyl]amino]ethyl]phenyl]-4-[4-[4-(trifluoromethyl)phenyl]thiazol-2-yl]benzenesulfonamide

Potent, selective 3-pyridylethanolamine β 3 adrenergic receptor agonists possessing a thiazole benzenesulfonamide pharmacophore

Physiological and pharmacological properties of vanadium

Synthesis and SAR of benzyl and phenoxymethylene oxadiazole benzenesulfonamides as selective β 3 adrenergic receptor agonist antiobesity agents

Discovery of an orally bioavailable alkyl oxadiazole β 3 adrenergic receptor agonist

Human β3 adrenergic receptor agonists containing cyclic ureidobenzenesulfonamides

3-pyridylethanolamines: Potent and selective human β 3 adrenergic receptor agonists

Human β3 andrenergic receptor agonists containing imidazolidinone and imidazolone benzenesulfonamides

Effects of acute blood volume expansion on vascular resistance and reactivity in anaesthetized dogs

Presynaptic inhibition of vascular sympathetic neurotransmission by adenosine

In vivo hemodynamic effects of endothelium-derived constricting factor in the dog

Suchergebnisse filtern